EN
Team
-
Dr. Liang Tao Group Medical DirectorLiang Tao has three decades of clinical experience in cardiovascular surgery. In 2010, he was awarded the "Golden Scalpel Award" by the Chinese Association for Cardiovascular Surgeons. He specializes in a wide range of surgical procedures, including complex congenital heart disease, minimally invasive valve surgery, coronary artery disease, macrovascular disease, cardiac tumours, and heart transplantation. Dr. Tao has also pioneered unique techniques for unicuspid, bicuspid, and tricuspid aortic valve reconstruction, earning widespread acclaim from cardiovascular experts in China and internationally.
-
Dr. Xi Su Hospital President, Professor, and Postgraduate SupervisorExpert Member of the Chinese Medical Association, Vice Chairman of the Heart Rhythm Committee of the Chinese Medical Doctor Association, Executive Member of the Chinese College of Cardiovascular Physicians, Chairman of the Cardiovascular Disease Branch of the Chinese Non-Governmental Medical Institutions Association, Vice Chairman of the Cardiovascular Disease Branch of the China International Exchange and Promotion Association for Medical and Healthcare, Executive Vice Chairman of the Air Rescue Branch of the China Association for Disaster & Emergency Rescue Medicine, Vice Chairman of the Cardiac Rehabilitation Management Committee of the Chinese Hospital Association, Member of the National Cardiovascular Disease Expert Committee.
-
Dr. Hua Yan Hospital President of Wuhan Asia Heart HospitalDr. Yan graduated from Peking University Health Science Center with a Doctorate in Internal Medicine (Cardiovascular Medicine). She has 29 years of clinical cardiovascular experience, including 19 years of interventional treatment experience in coronary artery disease.
Dr. Yan specialises in the clinical treatment of coronary artery disease, hypertension, heart failure, hyperlipidaemia, and complex/critical cardiovascular conditions. She has particularly in-depth expertise in interventional diagnosis and treatment of coronary artery disease, and has led or participated in over 12,500 complex interventional procedures, including treatment of left main coronary artery disease, arterial calcification, and chronic total occlusions. She is also one of China’s first cardiovascular clinicians to utilize cutting-edge coronary imaging and functional techniques, leveraging tools such as intravascular ultrasound, optical coherence tomography, and fractional flow reserve to diagnose complex coronary lesions, optimize percutaneous coronary interventions, and improve patient outcomes.
-
-
Dr. Xufa Chen Hospital PresidentDr. Chen completed a one-year cardiovascular surgery programme in Japan, as well as observational learning programs at Penn State Health Milton S. Hershey Medical Center and Memorial Hermann Hospital in Houston. He has contributed to a range of national, provincial and municipal scientific research projects, and has published numerous articles in leading Chinese academic journals.
He currently serves as Expert Advisor to the Wuhan Medical Accident Technical Appraisal Panel, Member of the Chinese Medical Doctor Association Vascular Surgery Committee, Member of the Cardiothoracic Surgery Branch of the Hubei Medical Association, Member of the Cardiothoracic Surgery Committee of the Wuhan Medical Association, and Expert Reviewer for the Hubei Province Clinical Specialty Program.
-
Dr. Tsutomu Fujita Chief of CardiologyDr. Fujita has many years of experience in the interventional treatment of coronary artery disease. In 2008, he established the Sapporo Cardiovascular Clinic to improve access to specialist cardiovascular care. Within three years, the clinic became one of Japan’s most renowned facilities for cardiovascular interventions.
Its success can be attributed to the dedicated team of staff, whose philosophy is to ensure early detection without relying on invasive diagnostic procedures that place an additional burden on patients. Since its opening, the clinic has attracted a dynamic and ambitious team of doctors, who frequently participate in academic conferences, research presentations, lectures, and training.
In 2012, the Sapporo Cardiovascular Clinic began offering cardiac surgery, becoming a fully-fledged hospital for all cardiovascular conditions. The clinic’s Director of Cardiovascular Surgery, Dr. Tsutomu Fujita, previously worked at Hokkaido Ohno Hospital, one of the region’s largest facilities for cardiovascular surgery. The Sapporo Cardiovascular Clinic is ranked fourth nationally and first in Hokkaido for cardiovascular medicine, as well as first in Hokkaido for cardiovascular surgery – an achievement of which I am immensely proud.
As a doctor at the Sapporo Cardiovascular Clinic, I hope to continue building on our achievements and make a meaningful contribution to Hokkaido’s healthcare sector.
-
-
Dr. Daisuke Hachinohe President2004 Graduated from the School of Medicine, Asahikawa Medical University
Certified Specialist, The Japanese Society of Internal Medicine (General Internal Medicine)
Certified Cardiologist, The Japanese Circulation Society
Certified Physician & Lecturer, Japan Primary Care Association
Certified Specialist, Japanese Association of Cardiovascular Intervention and Therapeutics
Certification for Implantable Cardioverter Defibrillator (ICD) / Cardiac Resynchronization Therapy (CRT) Implantation
Infection Control Doctor (ICD), The Japanese Association for Infectious Diseases
Transcatheter Aortic Valve Replacement (TAVR): Certified Operator, Lecturer, and Proctor for SAPIEN, CoreValve, and Navitor valve systems
Percutaneous Mitral Valve Repair (MitraClip): Proctor
Percutaneous Left Atrial Appendage Occlusion (LAAO): Proctor
Atrial Septal Defect (ASD) Closure: Certified
Patent Foramen Ovale (PFO) Closure: Certified
Patent Ductus Arteriosus (PDA) Closure: Certified
-
-
